Noromycin 300 La is a drug owned by NORBROOK LABORATORIES, LTD. It is protected by 2 US drug patents filed from 2020 to 2021. All patents have expired. Details of Noromycin 300 La’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US6110905 | 29 Aug, 2020 | Expired |
About Noromycin 300 La
Noromycin 300 La is a drug
owned by NORBROOK LABORATORIES, LTD.
Noromycin 300 La uses
Oxytetracycline Dihydrate as the active
ingredient.
Active Ingredient:
Noromycin 300 La uses
Oxytetracycline Dihydrate as the active ingredient.
Check out other Drugs and Companies using
Oxytetracycline Dihydrate ingredient.